NCT02757092

Brief Summary

The advantages of thoracoscopic surgery include smaller wounds, fewer postoperative complications, and shortened hospital stay. However,complications such as pain, pulmonary function insufficiency, pneumonia,postoperative pneumothorax, persistent air leakage, subcutaneous emphysema, cough, and hemoptysis may occur in older patients after thoracoscopic surgery. Pulmonary rehabilitation has been demonstrated by evidence-base medicine could effectively reduce pulmonary complications and dyspnea as well as improve lung function, quality of life, exercise ability, and functional status of patients after traditional heart and thoracic surgery. Studies have suggested that pulmonary rehabilitation should be performed for at least 4 weeks to optimize the training effect .However, most patients who undergo thoracoscopic surgery were discharged within 3-5 days. Such a short hospital stay impeded the delivery of pulmonary rehabilitation. Home-based pulmonary rehabilitation appeared to be an option for these patients The purpose of this study is to determine whether Pulmonary rehabilitation are effective on patients who had thoracic surgeries.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2016

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 31, 2016

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2016

Completed
17 days until next milestone

First Posted

Study publicly available on registry

April 29, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2017

Completed
3.4 years until next milestone

Results Posted

Study results publicly available

November 3, 2020

Completed
Last Updated

November 3, 2020

Status Verified

October 1, 2020

Enrollment Period

1 year

First QC Date

April 12, 2016

Results QC Date

December 15, 2017

Last Update Submit

October 10, 2020

Conditions

Keywords

Pulmonary rehabilitationsurgeryexercise

Outcome Measures

Primary Outcomes (3)

  • Discharge 2weeks Exercise Capacity

    Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise . The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M)higher scores mean a better outcome.

    assessed at discharge 2weeks

  • Discharge 6 Weeks Exercise Capacity

    Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise . The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M)higher scores mean a better outcome.

    assessed at discharge.6weeks

  • Discharge 12 Weeks Exercise Capacity

    Exercise capacity as assessed by 6 min walking test(M).The 6-min walk test (6 MWT) is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes. The 6-minute walk distance (6 MWD) provides a measure for integrated global response of multiple cardiopulmonary and musculoskeletal systems involved in exercise . The 6 MWT provides information regarding functional capacity, response to therapy and prognosis across a broad range of chronic cardiopulmonary conditions .The normal range in aged patients 60-69 y(male 572 m,female 538 M),70-79 y(male 527 m,female 471 M),80-89 y(male 417 m,female 392 M).higher scores mean a better outcome.

    assessed at discharge 12 weeks

Secondary Outcomes (27)

  • Discharge 2 Weeks Forced Vital Capacity (FVC in Liter(L)/Sec)

    assessments at 2 weeks after discharge

  • Discharge 2weeks Forced Expiratory Volume in 1 Second(FEV1,Liter(L)/Sec)

    assessed at 2 weeks after discharge

  • Discharge 2weeks MMEF 25-75%(Liter(L)/Sec)

    assessed at discharge 2weeks

  • Discharge 2weeks Peak Expiratory Flow Rate(PEFR , Liter(L)/Sec)

    assessed at discharge 2weeks

  • Discharge 2weeks Inspiratory Muscle Strength(MIP,cmH2O)

    assessed at discharge 2 weeks.

  • +22 more secondary outcomes

Study Arms (2)

Home-based rehabilitation program

EXPERIMENTAL

0-2 weeks,1. aerobic exercise intensity was targeted to reach 10-11 points of perceived exercise (RPE) scale 2. raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min 3.walked at a comfortable speed for 15 min twice per day.4. Triflo-II was performed 8-10 times per hour. inspiratory muscle training with the initial pressure set at 25%-30% of the maximum inspiratory pressure.3-6 weeks, aerobic exercise reach 12-15 points on the RPE scale. upper-limb resistance exercise (raising of a 250-cc water bottle) and lower-limb stepping for 20 min per day , walking exercise for a total of 30 min. Triflo-II was performed 8-10 times per hour, and train the inspiratory muscle with the pressure intensity adjusted to more than 5% of that in the first stage.

Other: Home-based Pulmonary Rehabilitation

standard care

ACTIVE COMPARATOR

control group accept the pulmonary rehabilitation (breathing exercise, extremities exercise, breathing muscle training, incentive spirometry (Triflo-II) training, intermittent positive pressure ventilation, chest physical therapy and pain control) only in operation stage on before op-day 3 day and after op-day and without home based pulmonary rehabilitation.

Other: Home-based Pulmonary Rehabilitation

Interventions

(1) breathing exercises (pursed-lip and diaphragmatic breathing) and coughing exercises, (2) aerobic exercises (upper and lower limb exercises and walking), (3) incentive spirometry training (Triflo-II), and (4) threshold load training of the inspiratory muscle. In the first stage (0-2 weeks), the aerobic exercise intensity was targeted to reach 10-11 points on the 20-point Borg rating of perceived exercise (RPE) scale. Patients raised their upper limbs while simultaneously performing lower-limb stepping at place for 20 min; in addition, they walked at a comfortable speed for 15 min twice per day. Incentive spirometry training (Triflo-II) was performed 8-10 times per hour. We used a threshold load trainer for inspiratory muscle training (30 breaths each time, twice per day) with the initial pressure set at 25%-30% of the maximum inspiratory pressure.

Home-based rehabilitation programstandard care

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Signed consent
  • The men and women over the age of 65
  • admission to undergo VATS.
  • consciousness and ability to communicate
  • ability to undergo 6 weeks of a home-based pulmonary rehabilitation program

You may not qualify if:

  • refusal to participate
  • unplanned emergency surgery
  • hemodynamic instability
  • received other surgery within a month postsurgery
  • unconsciousness after surgery
  • bedridden and upper or lower limb weakness
  • received radiation and chemotherapy postsurgery
  • implementation of thoracoscopic surgery for biopsy only

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Chang Gung Memorial Hospital

Kaohsiung City, Niaosong, 83342, Taiwan

Location

Chang Gung Memorial Hospital

Kaohsiung City, 83342, Taiwan

Location

MeSH Terms

Conditions

Lung NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesBehavior

Limitations and Caveats

First,sample size is low,this may affect the result of the study;secondly, pulmonary function should collect DLCO and MVV;third,although the patients were checked via telephone every week,there is no surefire way to enforce intervention.

Results Point of Contact

Title
Respiratory therapist Nai-Ying Kuo
Organization
Chang Gung Memorial Hospital

Study Officials

  • Jui Fang Liu, PhD

    Department of Respiratory Therapy

    STUDY DIRECTOR
  • Nai Ying Kuo, master

    Department of Respiratory Therapy

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
After participants signed the consent form, they were randomly included into the control or experimental group on the day of discharge
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This study employed a prospective, randomized, and controlled clinical design to determine the efficacy of home-based pulmonary rehabilitation in patients after thoracoscopy. After participants signed the consent form, they were randomly included into the control or experimental group on the day of discharge. The random assignment was performed based on simple randomization by using numbers from 1 to 36; numbered, sealed, opaque envelopes were used for allocation concealment. These envelopes were randomly distributed by non researchers and recorded.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Respiratory therapist

Study Record Dates

First Submitted

April 12, 2016

First Posted

April 29, 2016

Study Start

March 31, 2016

Primary Completion

April 1, 2017

Study Completion

May 31, 2017

Last Updated

November 3, 2020

Results First Posted

November 3, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

Share Protocol and Outcome deta

Shared Documents
STUDY PROTOCOL, CSR
Time Frame
starting 6 months after publication
Access Criteria
connect with miss Nai ying kuo and Share IPD by email

Locations